https://andards.com/tags/rapamycin/ Recent content in rapamycin on AndArds Hugo -- gohugo.io en-us Fri, 27 Mar 2026 07:33:00 +0000 https://andards.com/posts/rapamycin-vs.-metformin-the-great-longevity-drug-debate/ Fri, 27 Mar 2026 07:33:00 +0000 https://andards.com/posts/rapamycin-vs.-metformin-the-great-longevity-drug-debate/ The pursuit of extended healthspan, often termed “longevity,” has led to considerable interest in pharmacological interventions. Among the compounds frequently discussed are rapamycin and metformin, two drugs with distinct mechanisms of action but overlapping potential in influencing aging pathways. https://andards.com/posts/cycling-protein-and-rapamycin-can-we-have-our-cake-and-eat-it-too/ Fri, 13 Mar 2026 04:43:00 +0000 https://andards.com/posts/cycling-protein-and-rapamycin-can-we-have-our-cake-and-eat-it-too/ The quest for a longer, healthier life often involves navigating complex biological pathways. Two key players in this intricate dance are protein intake and the pharmaceutical rapamycin, both of which influence a central cellular regulator known as mTOR (mammalian Target of Rapamycin). https://andards.com/posts/rapamycin-for-longevity-the-current-human-trials-and-what-we-know/ Thu, 05 Mar 2026 22:40:00 +0000 https://andards.com/posts/rapamycin-for-longevity-the-current-human-trials-and-what-we-know/ Rapamycin, an immunosuppressant drug, has garnered significant attention in the longevity research community due to its documented ability to extend lifespan in various organisms. This article explores the current landscape of human trials investigating rapamycin for longevity, examining the scientific basis, ongoing studies, and the cautious optimism surrounding its potential as an anti-aging drug. https://andards.com/posts/rafael-de-cabo-and-the-nia-interventions-testing-program-what-actually-works/ Thu, 05 Mar 2026 20:34:00 +0000 https://andards.com/posts/rafael-de-cabo-and-the-nia-interventions-testing-program-what-actually-works/ The pursuit of understanding and extending healthy lifespan is a complex scientific endeavor. Key to this pursuit is rigorously testing interventions that might influence aging. The National Institute on Aging (NIA) Interventions Testing Program (ITP) stands as a critical initiative in this area, and Dr. https://andards.com/posts/the-dog-aging-project-what-matt-kaeberlein-is-learning-from-our-pets/ Sun, 01 Mar 2026 20:58:00 +0000 https://andards.com/posts/the-dog-aging-project-what-matt-kaeberlein-is-learning-from-our-pets/ The Dog Aging Project is a large-scale, longitudinal study investigating how genetics, lifestyle, and environment influence the health and longevity of companion dogs. Led by Dr. Matt Kaeberlein, a prominent researcher in the biology of aging, the project aims to gather extensive data from tens of thousands of dogs across the United States. https://andards.com/posts/matt-kaeberleins-rapamycin-research-the-most-promising-longevity-drug/ Tue, 24 Feb 2026 19:47:00 +0000 https://andards.com/posts/matt-kaeberleins-rapamycin-research-the-most-promising-longevity-drug/ Rapamycin, an immunosuppressant drug discovered in the 1970s, has garnered significant attention in the longevity research community. Among the key figures exploring its potential to extend healthy lifespan is Dr. Matt Kaeberlein, a professor of laboratory medicine and pathology at the University of Washington. https://andards.com/posts/mtor-inhibition-vs.-nad-boosting-which-pathway-matters-more-for-aging/ Mon, 09 Feb 2026 05:29:00 +0000 https://andards.com/posts/mtor-inhibition-vs.-nad-boosting-which-pathway-matters-more-for-aging/ The quest to understand and mitigate aging has led researchers down many complex biological pathways. Among the most prominent are the mechanistic target of rapamycin (mTOR) pathway and the nicotinamide adenine dinucleotide (NAD+) pathway. Both have garnered significant attention for their roles in cellular health, metabolism, and longevity. https://andards.com/posts/matt-kaeberlein-and-the-dog-aging-project-what-rapamycin-does-for-pets/ Sun, 04 Jan 2026 21:18:00 +0000 https://andards.com/posts/matt-kaeberlein-and-the-dog-aging-project-what-rapamycin-does-for-pets/ The prospect of extending healthy lifespan, for humans and their animal companions, drives much research in geroscience. At the forefront of this effort is Dr. Matt Kaeberlein, a recognized figure in aging research, and his involvement with the Dog Aging Project.